ACTIVE

Perrigo Belgium

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result9,7 M €+53,1 %over 1 year
Revenue44,6 M €-10,7 %over 1 year
Equity514,7 M €+3,3 %over 1 year
Workforce52,5 ETP-39,2 %over 1 year

Identity

Source · BCE/KBO

Perrigo Belgium is a Public limited company incorporated in 1977. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Gent. It employs on average 52,5 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0417.132.860
Incorporation
05/05/1977
Legal form
Public limited company
Registered office
Gaston Crommenlaan 6 box 606
9050 Gent · FlandreSee on map
Contributed capital
257 982 241,00 €
Latest accounts
31/12/2025
Average workforce
52,5 ETP
Joint committees (2)
  • 116
  • 207
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 20 filings

Trend over 19 financial years

20252023202220212020
Income statement
Revenue44,6 M €49,9 M €42,3 M €45,3 M €45,9 M €
EBITDA2 M €6 M €-150,9 k €1,8 M €3,2 M €
Operating result2,2 M €5,4 M €-430,6 k €1,3 M €2,6 M €
Net result9,7 M €6,3 M €33,6 M €1 M €-170,2 M €
Balance sheet
Equity514,7 M €498,2 M €491,9 M €458,3 M €684,6 M €
Total assets529,1 M €510,4 M €503,3 M €469,8 M €695,7 M €
Cash66,1 k €61 k €2,9 k €3,4 k €9 k €
Debts14,4 M €11,7 M €10,5 M €10,8 M €10,1 M €
Other
Workforce52,5 ETP86,3 ETP88,2 ETP93,6 ETP92,3 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 100 M€ and 250 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 47 ended

Active mandates

Ronald van Workum

Director · since 11 juin 2025 · until 09 mai 2031

Active
Magali Verbraeken

Director · since 08 janvier 2024 · until 08 janvier 2030

Active
Anja van Winsberghe

Director · since 18 janvier 2023 · until 17 janvier 2029

Active

Ended mandates

Magali Verbraeken

Director · since 26 février 2024 · until 25 février 2030

Ended
Caroline Van Hese

Director · since 06 décembre 2022 · until 26 février 2024

Ended
Caroline Van Hese

Director · since 06 décembre 2022 · until 05 décembre 2028

Ended
Mira De Maeyer

Director · since 17 mai 2021 · until 16 mai 2027

Ended

Other companies at this address

Gaston Crommenlaan 6 9050 Gent
CompanyCBE no.
BRAVX● Active
0834.939.871
LIGHTHOUSE INTELLIGENCE● Active
0676.420.293
Oce-Bio● Active
0442.861.022
omega pharma group● Active
0837.048.632
OMEGA PHARMA INNOVATION & DEVELOPMENT● Active
0884.084.724
OMEGA PHARMA INTERNATIONAL● Active
0807.596.363
OMEGA PHARMA TRADING● Active
0417.092.080
Perrigo Capital● Active
0430.784.027
Perrigo Europe Invest● Active
0439.658.834
Perrigo Holding● Active
0431.676.229
TM BRAVO4 CIVIEL● Active
0787.232.501
TM BRAVO-4 KOEPEL-EPC● Active
1008.974.796
TM Goedingebrug● Active
1039.143.281
TM Nieuwe Waasmunsterbrug over Durme● Active
1035.016.328

Full financial information

Source · NBB
202520242023202220212020
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date08/06/202618/06/202523/05/202425/05/202320/06/202214/06/2021
General meeting14/05/202608/05/202513/05/202411/05/202312/05/202217/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202514/05/202608/06/2026DutchPDF
Full model31/12/202408/05/202518/06/2025DutchPDF
Full model31/12/202313/05/202423/05/2024DutchPDF
Full model31/12/202211/05/202325/05/2023DutchPDF
Full model31/12/202112/05/202220/06/2022DutchPDF
Full model31/12/202017/05/202114/06/2021DutchPDF
Full model31/12/201914/05/202026/06/2020DutchPDF
Full model31/12/201809/05/201917/05/2019DutchPDF
Full model31/12/201726/05/201811/06/2018DutchPDF
Full model31/12/201627/05/201713/06/2017DutchPDF
Full model31/12/201529/09/201607/10/2016DutchPDF
Full model31/12/201430/05/201512/06/2015DutchPDF
Full model31/12/201331/05/201417/06/2014DutchPDF
Full model31/12/201225/05/201317/06/2013DutchPDF
Full model31/12/201126/05/201208/06/2012DutchPDF
Full model31/12/201002/06/201114/06/2011DutchPDF
Full model31/12/200929/05/201008/06/2010DutchPDF
Full model31/12/200830/05/200926/06/2009DutchPDF
Full model31/12/200723/06/200823/06/2008DutchPDF
Full model31/12/200626/05/200722/06/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 M€ and 250 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 47 ended

Active mandates

Ronald van Workum

Director · since 11 juin 2025 · until 09 mai 2031

Active
Magali Verbraeken

Director · since 08 janvier 2024 · until 08 janvier 2030

Active
Anja van Winsberghe

Director · since 18 janvier 2023 · until 17 janvier 2029

Active

Ended mandates

Magali Verbraeken

Director · since 26 février 2024 · until 25 février 2030

Ended
Caroline Van Hese

Director · since 06 décembre 2022 · until 26 février 2024

Ended
Caroline Van Hese

Director · since 06 décembre 2022 · until 05 décembre 2028

Ended
Mira De Maeyer

Director · since 17 mai 2021 · until 16 mai 2027

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates08/06/2026
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates22/12/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates15/10/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Restructuring25/07/2024
    RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Mandates18/06/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Restructuring16/05/2024
    RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...) - DIVERSEN
    PDF
  • Registered office15/04/2024
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - BENAMING - MAATSCHAPPELIJKE ZETEL - DIVERSEN
    PDF
  • Mandates07/03/2024
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 22/05/2026
    nominationJonas Dhaenens — bestuurder
  2. 2025
    Annual accounts 20259,7 M €↑
  3. 11/06/2025
    nominationRonald van Workum — bestuurder
  4. 08/05/2025
    nominationBDO Bedrijfsrevisoren BV — commissaris
  5. 29/08/2024
    nominationDiogo Charneca — bestuurder
  6. 13/05/2024
    reconductionPaul Eelen — commissaris
  7. 08/01/2024
    nominationMagali Verbraeken — bestuurder
  8. 2023
    Annual accounts 20236,3 M €↓
  9. 18/01/2023
    nominationAnja van Winsberghe — bestuurder
  10. 18/01/2023
    nominationMira De Maeyer — gedelegeerd bestuurder
  11. 2023
    Name changePERRIGO BELGIUM
  12. 2022
    Annual accounts 202233,6 M €↑
  13. 06/12/2022
    nominationCaroline Van Hese — bestuurder
  14. 11/05/2022
    autre
  15. 2021
    Annual accounts 20211 M €↑
  16. 2021
    Name changeOMEGA PHARMA BELGIUM
  17. 2020
    Annual accounts 2020-170,2 M €↓
  18. 2019
    Annual accounts 201919,3 M €↑
  19. 2018
    Annual accounts 2018-24,2 M €↑
  20. 2017
    Annual accounts 2017-31 M €↑
  21. 2016
    Annual accounts 2016-162,8 M €↓
  22. 2015
    Annual accounts 2015-45,1 M €↓
  23. 2014
    Annual accounts 2014-25,7 M €↓
  24. 2013
    Annual accounts 2013-14,9 M €↓
  25. 2012
    Annual accounts 20124,3 M €↓
  26. 2011
    Annual accounts 20116,3 M €↓
  27. 2010
    Annual accounts 20109,7 M €↓
  28. 2009
    Annual accounts 200911,6 M €↑
  29. 2008
    Annual accounts 20086,5 M €↑
  30. 2007
    Annual accounts 2007-2,1 M €↓
  31. 2006
    Annual accounts 20062,4 M €
  32. 05/05/1977
    IncorporationPublic limited company